Related Experiment Video
Updated: May 18, 2026

An Efficient Single-Person Technique for Milk Sampling from Laboratory Mice
Published on: March 28, 2025
Health Canada advisory on domperidone should I avoid prescribing domperidone to women to increase milk production
Question:
I often prescribe domperidone to women as a galactagogue starting at a dose of 30 mg and increasing the dose as needed. In March of this year, Health Canada released an advisory warning of domperidone use and abnormal heart rhythms and sudden cardiac death. Should I cap doses at 30 mg or stop prescribing domperidone all together to these women?
Answer:
The Health Canada warning is based on 2 studies. The results of the studies are not directly applicable to breastfeeding and should not change the way you normally manage otherwise healthy breastfeeding women.
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drug Dosing: Infants and Children
Drug Dosing: Obese Patients
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Teratogenicity
Drug Dosing: Geriatric Patients

